<table id="id_7613881c-8d3d-49e0-89cb-df0fbc955d95" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_42d844ce-c8a1-4805-b42e-f30429bb1aba">Table 1 Randomized Clinical Trials of Vinorelbine Tartrate in Combination with Cisplatin in NSCLC</caption>
<col align="left" width="30%"></col>
<col align="center" width="14%"></col>
<col align="center" width="14%"></col>
<col align="center" width="14%"></col>
<col align="center" width="14%"></col>
<col align="center" width="14%"></col>
<thead>
<tr id="id_e65075a0-c497-4453-8448-fb07e8f8e681" stylecode="Toprule">
<td align="left" stylecode="Botrule Rrule" valign="top"></td>
<td align="left" colspan="2" stylecode="Botrule Rrule" valign="top">Vinorelbine Tartrate/Cisplatin vs. Single-Agent Cisplatin</td>
<td align="left" colspan="3" stylecode="Lrule Botrule" valign="top">Vinorelbine Tartrate/Cisplatin vs. Vindesine/Cisplatin vs. Single-Agent Vinorelbine Tartrate</td>
</tr>
<tr id="id_359ba5a2-60eb-4503-8059-2054b08949f7" stylecode="Botrule">
<td align="left" stylecode="Botrule Rrule" valign="top"></td>
<td align="left" stylecode="Botrule Rrule" valign="top">Vinorelbine Tartrate/<br/>Cisplatin</td>
<td align="left" stylecode="Botrule Rrule" valign="top">Cisplatin</td>
<td align="left" stylecode="Botrule Rrule" valign="top">Vinorelbine Tartrate/<br/>Cisplatin</td>
<td align="left" stylecode="Botrule Rrule" valign="top">Vindesine/<br/>Cisplatin</td>
<td align="left" stylecode="Lrule Botrule" valign="top">Vinorelbine Tartrate</td>
</tr>
</thead>
<tbody>
<tr id="id_88022535-b59f-41f8-8e7a-167edeed7f5a" stylecode="Toprule">
<td align="left" valign="top">
<content stylecode="bold">Demographics</content>
</td>
<td align="left" stylecode="Toprule" valign="top"></td>
<td align="left" stylecode="Rrule" valign="top"></td>
<td align="left" stylecode="Toprule" valign="top"></td>
<td align="left" stylecode="Toprule" valign="top"></td>
<td align="left" valign="top"></td>
</tr>
<tr id="id_af836f20-242f-4a58-8142-0aa848ba6305">
<td align="left" valign="top">  Number of patients</td>
<td align="left" valign="top">214</td>
<td align="left" stylecode="Rrule" valign="top">218</td>
<td align="left" valign="top">206</td>
<td align="left" valign="top">200</td>
<td align="left" valign="top">206</td>
</tr>
<tr id="id_8dafada1-a8d2-429f-8351-41421f1987d3">
<td align="left" valign="top">    Number of males</td>
<td align="left" valign="top">146</td>
<td align="left" stylecode="Rrule" valign="top">141</td>
<td align="left" valign="top">182</td>
<td align="left" valign="top">179</td>
<td align="left" valign="top">188</td>
</tr>
<tr id="id_84182f07-6c23-4c8f-9030-3ca54b10cb78">
<td align="left" valign="top">    Number of females</td>
<td align="left" valign="top">68</td>
<td align="left" stylecode="Rrule" valign="top">77</td>
<td align="left" valign="top">24</td>
<td align="left" valign="top">21</td>
<td align="left" valign="top">18</td>
</tr>
<tr id="id_5ded595e-91ea-449f-bcec-12f0e2d18f08">
<td align="left" valign="top">  Median age (years)</td>
<td align="left" valign="top">63</td>
<td align="left" stylecode="Rrule" valign="top">64</td>
<td align="left" valign="top">59</td>
<td align="left" valign="top">59</td>
<td align="left" valign="top">60</td>
</tr>
<tr id="id_a5d26fbc-7d2f-4a36-a0bc-580294d2d821">
<td align="left" valign="top">  Range (years)</td>
<td align="left" valign="top">33 to 84</td>
<td align="left" stylecode="Rrule" valign="top">37 to 81</td>
<td align="left" valign="top">32 to 75</td>
<td align="left" valign="top">31 to 75</td>
<td align="left" valign="top">30 to 74</td>
</tr>
<tr id="id_7f8542de-6660-4f3a-aa0d-504580c0ffad">
<td align="left" valign="top">  Stage of disease</td>
<td align="left" valign="top"></td>
<td align="left" stylecode="Rrule" valign="top"></td>
<td align="left" valign="top"></td>
<td align="left" valign="top"></td>
<td align="left" valign="top"></td>
</tr>
<tr id="id_34831245-9477-46a7-babf-6492c598ca68">
<td align="left" valign="top">    Stage IIIA</td>
<td align="left" valign="top">N/A</td>
<td align="left" stylecode="Rrule" valign="top">N/A</td>
<td align="left" valign="top">11%</td>
<td align="left" valign="top">11%</td>
<td align="left" valign="top">10%</td>
</tr>
<tr id="id_0e992249-ad98-425b-a4cb-c6fd5c6bf2af">
<td align="left" valign="top">    Stage IIIB</td>
<td align="left" valign="top">8%</td>
<td align="left" stylecode="Rrule" valign="top">8%</td>
<td align="left" valign="top">28%</td>
<td align="left" valign="top">25%</td>
<td align="left" valign="top">32%</td>
</tr>
<tr id="id_23f81864-5bf1-4c3a-a4a1-0664da5847ab">
<td align="left" valign="top">    Stage IV</td>
<td align="left" valign="top">92%</td>
<td align="left" stylecode="Rrule" valign="top">92%</td>
<td align="left" valign="top">50%</td>
<td align="left" valign="top">55%</td>
<td align="left" valign="top">47%</td>
</tr>
<tr id="id_ee4cad0e-9c70-4f70-a2b5-cfa07a0dbcb3">
<td align="left" valign="top">    Local recurrence</td>
<td align="left" valign="top">N/A</td>
<td align="left" stylecode="Rrule" valign="top">N/A</td>
<td align="left" valign="top">2%</td>
<td align="left" valign="top">3%</td>
<td align="left" valign="top">3%</td>
</tr>
<tr id="id_18cf04a4-9ff7-4abd-8525-7589c1851017">
<td align="left" valign="top">    Metastatic after surgery</td>
<td align="left" valign="top">N/A</td>
<td align="left" stylecode="Rrule" valign="top">N/A</td>
<td align="left" valign="top">9%</td>
<td align="left" valign="top">8%</td>
<td align="left" valign="top">9%</td>
</tr>
<tr id="id_0978a4f6-63f8-4f85-9cdc-5c45043fe6fd">
<td align="left" valign="top">  Histology</td>
<td align="left" valign="top"></td>
<td align="left" stylecode="Rrule" valign="top"></td>
<td align="left" valign="top"></td>
<td align="left" valign="top"></td>
<td align="left" valign="top"></td>
</tr>
<tr id="id_81763e1f-4996-4f34-9881-50d58709dd6b">
<td align="left" valign="top">    Adenocarcinoma</td>
<td align="left" valign="top">54%</td>
<td align="left" stylecode="Rrule" valign="top">52%</td>
<td align="left" valign="top">32%</td>
<td align="left" valign="top">40%</td>
<td align="left" valign="top">28%</td>
</tr>
<tr id="id_ad3a4581-9b38-4c78-ac4b-0a597419e996">
<td align="left" valign="top">    Squamous</td>
<td align="left" valign="top">19%</td>
<td align="left" stylecode="Rrule" valign="top">22%</td>
<td align="left" valign="top">56%</td>
<td align="left" valign="top">50%</td>
<td align="left" valign="top">56%</td>
</tr>
<tr id="id_541698fe-9d7f-4613-9fd5-27ac5ffcc013">
<td align="left" valign="top">    Large cell</td>
<td align="left" valign="top">14%</td>
<td align="left" stylecode="Rrule" valign="top">14%</td>
<td align="left" valign="top">13%</td>
<td align="left" valign="top">11%</td>
<td align="left" valign="top">16%</td>
</tr>
<tr id="id_3f945c3c-4f16-497d-9116-e03db9e374e7">
<td align="left" valign="top">    Unspecified</td>
<td align="left" valign="top">13%</td>
<td align="left" stylecode="Rrule" valign="top">13%</td>
<td align="left" valign="top">N/A</td>
<td align="left" valign="top">N/A</td>
<td align="left" valign="top">N/A</td>
</tr>
<tr id="id_0d3e2579-ea97-4ea4-a572-09e62c6355fa">
<td align="left" valign="top">
<content stylecode="bold">Results</content>
<br/>  Median survival (months)</td>
<td align="left" valign="top">7.8</td>
<td align="left" stylecode="Rrule" valign="top">6.2</td>
<td align="left" valign="top">9.2<footnote id="id-b89ed336-a7be-4610-a077-2b97cfac4bb2">
<content stylecode="italics">P</content> = 0.09 vs. vindesine/cisplatin</footnote>
<footnote id="id-c4b52fcd-26a9-4606-966f-03134faabddf">= 0.05 vs. single-agent vinorelbine</footnote>
</td>
<td align="left" valign="top">7.4</td>
<td align="left" valign="top">7.2</td>
</tr>
<tr id="id_f02bb269-90fc-42b1-bd98-1b2aaada8af9">
<td align="left" valign="top">  <content stylecode="italics">P</content> value</td>
<td align="left" colspan="2" stylecode="Rrule" valign="top">
<content stylecode="italics">P</content> = 0.01</td>
<td align="left" colspan="3" valign="top"></td>
</tr>
<tr id="id_33a34e92-dd5e-4f29-a8db-556965a512e4">
<td align="left" valign="top">  12-Month survival rate</td>
<td align="left" valign="top">38%</td>
<td align="left" stylecode="Rrule" valign="top">22%</td>
<td align="left" valign="top">35%</td>
<td align="left" valign="top">27%</td>
<td align="left" valign="top">30%</td>
</tr>
<tr id="id_e7480091-ad7f-4a68-a0c8-c98812bff2dc">
<td align="left" valign="top">  Overall response</td>
<td align="left" valign="top">19%</td>
<td align="left" stylecode="Rrule" valign="top">8%</td>
<td align="left" valign="top">28%<footnote id="id-64563975-8829-46c3-9b20-04fe5967f3c4">
<content stylecode="italics">P</content> = 0.03 vs. vindesine/cisplatin</footnote>
<footnote id="id-93592937-5185-4122-ae4e-4021ec00887e">
<content stylecode="italics">P</content>&lt;0.001 vs. single-agent vinorelbine</footnote>
</td>
<td align="left" valign="top">19%</td>
<td align="left" valign="top">14%</td>
</tr>
<tr id="id_7622cc26-7358-4e88-b8b1-6e544a57df92" stylecode="Botrule">
<td align="left" valign="top">  <content stylecode="italics">P</content> value</td>
<td align="left" colspan="2" stylecode="Rrule" valign="top">
<content stylecode="italics">P</content> &lt; 0.001</td>
<td align="left" colspan="3" valign="top"></td>
</tr>
</tbody>
</table>